Literature DB >> 20547386

Double stranded RNA- relative to other TLR ligand-activated dendritic cells induce extremely polarized human Th1 responses.

Risa K Benwell1, Jennifer E Hruska, Kevin L Fritsche, David R Lee.   

Abstract

To better understand the relative efficiencies of using different TLR ligand-activated DCs to induce human CD4(+) T lymphocyte responses, human DCs were activated with two viral and two bacterial TLR ligands, and their production of IL12, TNFalpha, and IL10 was examined. While the two viral TLR ligands (ssRNA and dsRNA) induced DC production of detectable levels of IL12p70, DCs activated by the two bacterial TLR ligands (LPS and flagellin) induced increased proliferation of human allogeneic naïve CD4(+) T cells. dsRNA-activated DCs induced increased Th1 and decreased Th2 differentiation, resulting in extremely polarized responses relative to those induced by unstimulated and other TLR ligand-activated DCs. Neutralization of IL12p70 abrogated most of the Th1 skewing induced by all TLR ligand-activated moDCs. Collectively, these results demonstrate that dsRNA-activated DCs induce more highly polarized human Th1 responses than the other TLR ligand-activated DCs tested here. These results have implications for TLR ligands in immunotherapy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547386     DOI: 10.1016/j.cellimm.2010.05.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

2.  Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3.

Authors:  Marla Karine Amarante; Julie Massayo Maeda Oda; Edna Maria Vissoci Reiche; Helena Kaminami Morimoto; Mateus Nobrega Aoki; Maria Angelica Ehara Watanabe
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

3.  Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.

Authors:  Eva Lion; Sébastien Anguille; Zwi N Berneman; Evelien L J M Smits; Viggo F I Van Tendeloo
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

4.  Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection.

Authors:  Meera R Gupta; Deepthi Kolli; Roberto P Garofalo
Journal:  Respir Res       Date:  2013-07-05

Review 5.  Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Authors:  Charleen M L Chan Wah Hak; Antonio Rullan; Emmanuel C Patin; Malin Pedersen; Alan A Melcher; Kevin J Harrington
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

6.  Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.

Authors:  Meera R Gupta; Deepthi Kolli; Claudio Molteni; Antonella Casola; Roberto P Garofalo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

7.  Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion.

Authors:  Yosuke Kano; Takahiro Iguchi; Hiroto Matsui; Keishi Adachi; Yukimi Sakoda; Tomoya Miyakawa; Shun Doi; Shoichi Hazama; Hiroaki Nagano; Yoshiya Ueyama; Koji Tamada
Journal:  Cancer Sci       Date:  2016-04       Impact factor: 6.716

Review 8.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Authors:  Ruan F V Medrano; Aline Hunger; Samir Andrade Mendonça; José Alexandre M Barbuto; Bryan E Strauss
Journal:  Oncotarget       Date:  2017-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.